Basic information Safety Supplier Related

5-FLUORO-1H-INDOLE-7-CARBALDEHYDE

Basic information Safety Supplier Related

5-FLUORO-1H-INDOLE-7-CARBALDEHYDE Basic information

Product Name:
5-FLUORO-1H-INDOLE-7-CARBALDEHYDE
Synonyms:
  • 5-FLUORO-INDOLE-7-CARBOXALDEHYDE
  • 5-FLUORO-1H-INDOLE-7-CARBALDEHYDE
  • 1H-Indole-7-carboxaldehyde,5-fluoro-(9CI)
  • 5-Fluoro-1H-indole-7-carboxaldehyde
  • 5-Fluoro-7-formyl-1H-indole
  • 5-Fluoroindole-7-carbaldehyde
  • 1H-Indole-7-carboxaldehyde, 5-fluoro-
  • 5-Fluoro-1h-indole-8-carbaldehyde
CAS:
603306-52-1
MF:
C9H6FNO
MW:
163.15
Product Categories:
  • HALIDE
Mol File:
603306-52-1.mol
More
Less

5-FLUORO-1H-INDOLE-7-CARBALDEHYDE Chemical Properties

storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
More
Less

Safety Information

HS Code 
2933998090
More
Less

5-FLUORO-1H-INDOLE-7-CARBALDEHYDE Usage And Synthesis

Synthesis

1826-67-1

603306-58-7

603306-52-1

5-Fluoro-1H-indole-7-carboxaldehyde (0041) was synthesized as follows: vinylmagnesium bromide (1M tetrahydrofuran solution, 85.2 mL, 85.2 mmol) was slowly added dropwise to a solution of 2-dibutoxymethyl-4-fluoro-1-nitrobenzene (8.5 g, 28.4 mmol) in tetrahydrofuran (250 mL) at -78 °C. The reaction mixture was warmed at -45°C to -50°C for 30 min before being cooled again to -78°C and vinylmagnesium bromide (1 M solution in tetrahydrofuran, 85.2 mL, 85.2 mmol) was added dropwise. Subsequently, the mixture was kept at -45 °C to -50 °C for 20 min before the reaction was terminated by the addition of saturated aqueous ammonium chloride solution (300 mL). After warming the mixture to room temperature, it was extracted with ether (200 mL x 2). The combined organic phases were washed with saturated aqueous sodium chloride (400 mL x 2), dried over sodium sulfate and concentrated under reduced pressure. The residue was dissolved in tetrahydrofuran (100 mL), 0.5N HCl (10 mL) was added and stirred for 20 min. The reaction mixture was diluted with ether (200 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution (200 mL x 3) and saturated aqueous sodium chloride solution (200 mL x 2). The organic phase was dried over sodium sulfate and concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using 5% to 10% hexane solution of ethyl acetate as eluent to give a light yellow solid target product (2.6 g, 56% yield). The product was confirmed by 1H-NMR (300 MHz, CDCl3): δ 10.07 (s, 1H), 10.05 (br s, 1H), 7.62 (d, J=7.6 Hz, 1H), 7.42-7.39 (m, 2H), 6.60 (d, J=5.4 Hz, 1H).

References

[1] Patent: US2018/214458, 2018, A1. Location in patent: Paragraph 0336-0338
[2] Patent: WO2018/191350, 2018, A1. Location in patent: Paragraph 0284
[3] Patent: EP2173348, 2015, B1. Location in patent: Paragraph 0041
[4] Journal of Medicinal Chemistry, 2004, vol. 47, # 16, p. 3934 - 3937
[5] Patent: WO2003/76442, 2003, A1. Location in patent: Page/Page column 66

5-FLUORO-1H-INDOLE-7-CARBALDEHYDESupplier

Wuhan TCASChem Technology Co., Ltd.
Tel
027-86697669 13986148687
Email
sales@tcaschem.com
Shanghai potentpharm CO.,Ltd
Tel
13524892556
Email
sales-cn@potentpharm.com
SynAsst Chemical.
Tel
021-60343070
ShangHai AmK Pharmaceutical Technology Co., Ltd.
Tel
微信 17321281695 18019252918
Email
sale@amkchem.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com